| 摘要 |
<p>A composition for therapeutic or diagnostic use in connection with the toxine of Shigella Dysenteriae. As an active constituent the composition contains or consists of a compound having the formula (I):
<Chemistry id="chema01" num="0001"><Image id="ia01" he="35" wi="119" file="IMGA0001.TIF" imgContent="chem" imgFormat="TIFF" inline="no" /></Chemistry>wherein R, is hydrogen or an organic residue, and R<Sub>2</Sub> is hydrogen, alkyl, alkoxi or a carbohydric residue with the proviso that R<Sub>2</Sub> is not β-D-GaINacp-(1-0) when R, is D-Glc or -β-D-Glcp-(1-0)-ceramide and that R<Sub>2</Sub> is different from OH,
<UnorderedLists id="ula01" listStyle="none"><ListItem>α-D-GalNAcp-(1-3)-β-D-GalNAcp-(1-0)-.</ListItem><ListItem>ß-D-GalNAcp-(1-3)-β-D-GaINAcp-(1-0)-,</ListItem><ListItem>α-L-Fucp-(1-2)-β-D-Galp-(1-3)-f3-D-GaINAcp-(1-0)- and</ListItem><ListItem>α-L-Fucp-11-2)-α-D-Galp-(1-3)-(1-0)-;</ListItem><ListItem>a method for therapeutic treatment; and</ListItem></UnorderedLists>
the use of the composition for therapeutic treatment or diagnosis.</p> |
